Weiss Multi-Strategy Advisers’s Epizyme, Inc EPZM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,000	Closed	-$50K	–	837
2021 Q4	$50K	Sell	20,000 -4,037	-17%	-$15.9K	﹤0.01%	632
2021 Q3	$123K	Sell	24,037 -2,124	-8%	-$12.9K	﹤0.01%	651
2021 Q2	$217K	Buy	26,161 +934	+4%	+$7.87K	0.01%	616
2021 Q1	$220K	Sell	25,227 -307	-1%	-$3.18K	0.01%	642
2020 Q4	$277K	Sell	25,534 -1,770	-6%	-$21.8K	0.01%	624
2020 Q3	$326K	Buy	27,304 +4,579	+20%	+$61.3K	0.01%	510
2020 Q2	$365K	Sell	22,725 -2,352	-9%	-$41.1K	0.01%	487
2020 Q1	$389K	Sell	25,077 -4,923	-16%	-$106K	0.02%	359
2019 Q4	$738K	Sell	30,000 -35,000	-54%	-$520K	0.02%	513
2019 Q3	$670K	Hold	65,000	–	–	0.02%	472
2019 Q2	$816K	Sell	65,000 -10,000	-13%	-$129K	0.03%	391
2019 Q1	$929K	Sell	75,000 -10,000	-12%	-$112K	0.03%	403
2018 Q4	$524K	Buy	85,000 +45,000	+113%	+$344K	0.03%	345
2018 Q3	$424K	Buy	40,000 +12,659	+46%	+$145K	0.02%	455
2018 Q2	$370K	Buy	27,341 +12,341	+82%	+$192K	0.01%	502
2018 Q1	$266K	Buy	+15,000	New	+$253K	0.01%	492